コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ger association with the wild-type allele of ataxin-7.
2 ork have altered expression in the retina of Ataxin-7(266Q/+) mice suggesting an in vivo functional r
3 ssion of the caspase-7 truncation product of ataxin-7-69Q or -92Q, which removes the putative nuclear
6 ted or reversed SCA7 motor symptoms, reduced ataxin-7 aggregation in Purkinje cells (PCs), and preven
10 be used to silence the endogenous allele of ataxin 7 and replace it with an exogenous copy of the ge
11 mine disease proteins (huntingtin, ataxin-1, ataxin-7 and androgen receptor) via polyglutamine sequen
14 e we identified and characterized Drosophila Ataxin-7 and found that reduction of Ataxin-7 protein re
17 diffuse distribution throughout the nucleus, ataxin-7 associated with the nuclear matrix and the nucl
18 cleavable D266N/D344N form of polyQ-expanded ataxin-7 attenuated cell death, aggregate formation, and
20 subunit of the P/Q-type calcium channel, and ataxin-7 (ATXN7), a component of a chromatin-remodeling
22 thus, suggest that proteolytic processing of ataxin-7 by caspase-7 may contribute to SCA7 disease pat
25 tion mouse model by inserting a loxP-flanked ataxin-7 cDNA with 92 repeats into the translational sta
26 -7) disrupts the function of visual arrestin-ataxin-7 chimera, it enhances the function of beta-arres
28 We also detected N-terminal polyQ-expanded ataxin-7 cleavage products in SCA7 transgenic mice simil
30 polyQ-expanded form of ataxin-7 produces an ataxin-7 D266N/D344N protein that is resistant to caspas
34 nt in the putative phosphate-binding site of ataxin-7) disrupts the function of visual arrestin-ataxi
35 cipitation, it was demonstrated that Crx and ataxin-7 engage in a functionally significant interactio
39 on sequence (NLS) was confirmed by fusing an ataxin-7 fragment with the normally cytoplasmic protein
41 molecular layer thinning, while excision of ataxin-7 from PCs and inferior olive provided significan
50 antly, in relation to SCA7, poly(Q)-expanded ataxin-7 gets incorporated into STAGA and, in a dominant
53 y reported that directed expression of polyQ-ataxin-7 in Bergmann glia (BG) in transgenic mice leads
54 egeneration, and generated mice that express ataxin-7 in Bergmann glia of the cerebellum with the Gfa
57 ence of expression of polyglutamine-expanded ataxin-7 in Purkinje cells, we documented severe Purkinj
58 we examined the subcellular localization of ataxin-7 in transfected COS-1 cells using SCA7 cDNA clon
59 etected an N-terminal truncation fragment of ataxin-7 in transgenic mice and in SCA7 patient material
61 When we examined the consequences of reduced Ataxin-7 in vivo, we found that flies exhibited pronounc
62 taxin-7 was barely detectable, as was mutant ataxin-7 in young animals; with increasing age, however,
70 on of both SAGA and SLIK, and that the human ataxin-7 is able to compliment the loss of Sca7 in yeast
75 nerable had relatively high levels of mutant ataxin-7; it is interesting, however, that marked dysfun
78 at inhibition of caspase-7 cleavage of polyQ-ataxin-7 may be a promising therapeutic strategy for thi
80 ates ataxin-7 gene expression, we introduced ataxin-7 mini-genes into mice, and found that CTCF is re
83 -7 cleavage site is an important mediator of ataxin-7 neurotoxicity, suggesting that inhibition of ca
84 neuropathology revealed by this reporter and ataxin-7 nuclear inclusions in the vulnerable neurons.
86 uence similarity, we introduced the putative ataxin-7 phosphate-binding site into visual arrestin and
87 cleavage sites in the polyQ-expanded form of ataxin-7 produces an ataxin-7 D266N/D344N protein that i
88 sophila Ataxin-7 and found that reduction of Ataxin-7 protein results in loss of components from the
89 xpansion within the N-terminal region of the ataxin-7 protein, a known subunit of the SAGA complex.
90 Polyglutamine (polyQ) expansion within the ataxin-7 protein, a member of the STAGA [SPT3-TAF(II)31-
91 by a polyglutamine (polyQ) expansion in the ataxin-7 protein, categorizing SCA7 as one member of a l
95 whether a causal relationship exists between ataxin-7 proteolysis and in vivo SCA7 disease progressio
96 e that glutamine expansion stabilizes mutant ataxin-7, provide an explanation for selective neuronal
97 d adjacent to the caspase-7 cleavage site of ataxin-7 regulates turnover of the truncation product in
99 lts in increased H2B ubiquitination, loss of Ataxin-7 results in decreased H2B ubiquitination and H3K
101 s localized to its glutamine-rich region and ataxin-7's Crx binding domain was mapped to its glutamin
104 a suggest that the arrestin-like site in the ataxin-7 sequence is a functional phosphate-binding site
107 he presence of the phosphate-binding site in ataxin-7 suggests that this protein may be involved in p
109 RNAs, and introduce silent mutations into an ataxin 7 transgene such that it is resistant to their ef
110 sis of the Crx-ataxin-7 interaction, Crx and ataxin-7 truncation and point mutants were generated, an
112 Bergmann glia-specific expression of mutant ataxin-7 was sufficient to produce ataxia and neurodegen
113 thogenesis of SCA7 and possible functions of ataxin-7, we examined the subcellular localization of at
114 ne-rod homeobox protein (CRX) interacts with ataxin-7, we performed further studies to assess this in
115 ear inclusions composed of transgene-derived ataxin-7, which contains a pathogenic polyglutamine expa
116 homologue of the human SCA7-encoded protein ataxin-7, which, in its polyglutamine expanded pathologi
118 e produced SCA7 transgenic mice that express ataxin-7 with 24 or 92 glutamines in all neurons of the
120 ed transgenic mice expressing polyQ-expanded ataxin-7 with a second-site mutation (D266N) to prevent
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。